PPARγ is a key target of butyrate-induced caspase-3 activation in the colorectal cancer cell line Caco-2

Apoptosis

Volumn 11, Issue 10, 2006, Pages 1801-1811

  Schwab, Markus ^a   Reynders, Veerle ^a   Ulrich, Sandra ^a   Zahn, Nadine ^a   Stein, Jürgen ^a   Schröder, Oliver ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Apoptosis; Butyrate; Caspase 3; p38 MAPK; PPAR

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BUTYRIC ACID; CASPASE 3; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SURVIVIN; X LINKED INHIBITOR OF APOPTOSIS; BIRC5 PROTEIN, HUMAN; CASPASE 8; CASPASE 9; MICROTUBULE ASSOCIATED PROTEIN; TUMOR PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL STRAIN CACO 2; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INCUBATION TIME; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; WILD TYPE; BIOLOGICAL MODEL; COLORECTAL TUMOR; DRUG EFFECT; ENZYME ACTIVATION; GENETIC TRANSFECTION; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

BUTYRIC ACID; CACO-2 CELLS; CASPASE 3; CASPASE 8; CASPASE 9; COLORECTAL NEOPLASMS; ENZYME ACTIVATION; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PPAR GAMMA; TRANSFECTION; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 33748580708     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-006-9788-2     Document Type: Article

References (55)

1. Nakaji S, Ishiguro S, Iwane S, et al (2004) The prevention of colon carcinogenesis in rats by dietary cellulose is greater than the promotive effect of dietary lard as assessed by repeated endoscopic observation. J Nutr 134:935-939
2. Wachtershauser A, Stein J (2000) Rationale for the luminal provision of butyrate in intestinal diseases. Eur J Nutr 39:164-171
3. Klurfeld DM (1999) Nutritional regulation of gastrointestinal growth. Front Biosci 4:D299-302
4. Gaschott T, Steinhilber D, Milovic V, Stein J (2001) Tributyrin, a stable and rapidly absorbed prodrug of butyric acid, enhances antiproliferative effects of dihydroxycholecalciferol in human colon cancer cells. J Nutr 131:1839-1843
5. Wachtershauser A, Stein J (2001) Butyrate-induced differentiation of Caco-2 cells occurs independently from p27. Biochem Biophys Res Commun 281:295-299
6. Galfi P, Neogrady S, Kutas F, Veresegyhazy T (1985) Influence of sodium butyrate on HeLa cell morphology and proliferation. Life Sci 37:2257-2268
7. Cherbut C (1995) Role of gastrointestinal motility in the delay of absorption by dietary fibre. Eur J Clin Nutr 49(Suppl 3): S74-80
8. Toscani A, Soprano DR, Soprano KJ (1988) Molecular analysis of sodium butyrate-induced growth arrest. Oncogene Res 3:223-238
9. Rozental R, Faharani R, Yu Y, Johnson JM, Chan SO, Chiu FC (2004) Sodium butyrate induces apoptosis in MSN neuroblastoma cells in a calcium independent pathway. Neurochem Res 29:2125-2134
10. Velazquez OC, Rombeau JL (1997) Butyrate. Potential role in colon cancer prevention and treatment. Adv Exp Med Biol 427:169-181
11. Dashwood RH, Myzak MC, Ho E (2006) Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention? Carcinogenesis 27:344-349
12. Ruemmele FM, Schwartz S, Seidman EG, Dionne S, Levy E, Lentze MJ (2003) Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway. Gut 52:94-100
13. Shao Y, Gao Z, Marks PA, Jiang X (2004) Apoptotic and autophagic cell death induced by histone deacetylase inhibitors. Proc Natl Acad Sci USA 101:18030-18035
14. Li CJ, Elsasser TH (2005) Butyrate-induced apoptosis and cell cycle arrest in bovine kidney epithelial cells: involvement of caspase and proteasome pathways. J Anim Sci 83:89-97
15. McMillan L, Butcher SK, Pongracz J, Lord JM (2003) Opposing effects of butyrate and bile acids on apoptosis of human colon adenoma cells: differential activation of PKC and MAP kinases. Br J Cancer 88:748-753
16. Wesierska-Gadek J, Gueorguieva M, Wojciechowski J, Tudzarova-Trajkovska S (2004) In vivo activated caspase-3 cleaves PARP-1 in rat liver after administration of the hepatocarcinogen N-nitrosomorpholine (NNM) generating the 85 kDa fragment. J Cell Biochem 93:774-787
17. Liu X, Zou H, Slaughter C, Wang X (1997) DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89:175-184
18. Kumar S (1995) ICE-like proteases in apoptosis. Trends Biochem Sci 20:198-202
19. Nagata S (1997) Apoptosis by death factor. Cell 88:355-365
20. Cory S, Adams JM (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2:647-656
21. Zhang XD, Gillespie SK, Borrow JM, Hersey P (2003) The histone deacetylase inhibitor suberic bishydroxamate: a potential sensitizer of melanoma to TNF-related apoptosis-inducing ligand (TRAIL) induced apoptosis. Biochem Pharmacol 66:1537-1545
22. Wachtershauser A, Loitsch SM, Stein J (2000) PPAR-gamma is selectively upregulated in Caco-2 cells by butyrate. Biochem Biophys Res Commun 272:380-385
23. Ulrich S, Wachtershauser A, Loitsch S, von Knethen A, Brune B, Stein J (2005) Activation of PPARgamma is not involved in butyrate-induced epithelial cell differentiation. Exp Cell Res 310:196-204
24. Date M, Fukuchi K, Morita S, Takahashi H, Ohura K (2003) 15-Deoxy-delta12,14-prostaglandin J2, a ligand for peroxisome proliferators-activated receptor-gamma, induces apoptosis in human hepatoma cells. Liver Int 23:460-466
25. Gurnell M, Wentworth JM, Agostini M, et al (2000) A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis. J Biol Chem 275:5754-5759
26. Gupta RA, Brockman JA, Sarraf P, Willson TM, DuBois RN (2001) Target genes of peroxisome proliferator-activated receptor gamma in colorectal cancer cells. J Biol Chem 276:29681-29687
27. Miller SJ (2004) Cellular and physiological effects of short-chain fatty acids. Mini Rev Med Chem 4:839-845
28. Salminen A, Tapiola T, Korhonen P, Suuronen T (1998) Neuronal apoptosis induced by histone deacetylase inhibitors. Brain Res Mol Brain Res 61:203-206
29. Emanuele S, D'Anneo A, Bellavia G, et al (2004) Sodium butyrate induces apoptosis in human hepatoma cells by a mitochondria/caspase pathway, associated with degradation of beta-catenin, pRb and Bcl-XL. Eur J Cancer 40:1441-1452
30. Avivi-Green C, Polak-Charcon S, Madar Z, Schwartz B (2002) Different molecular events account for butyrate-induced apoptosis in two human colon cancer cell lines. J Nutr 132:1812-1818
31. Maher P (1999) p38 mitogen-activated protein kinase activation is required for fibroblast growth factor-2-stimulated cell proliferation but not differentiation. J Biol Chem 274:17491-17498
32. Cho SD, Ahn NS, Jung JW, et al (2006) Critical role of the c-JunNH2-terminal kinase and p38 mitogen-activated protein kinase pathways on sodium butyrate-induced apoptosis in DU145 human prostate cancer cells. Eur J Cancer Prev 15:57-63
33. Nick JA, Young SK, Brown KK, et al (2000) Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation. J Immunol 164:2151-2159
34. Nagata Y, Takahashi N, Davis RJ, Todokoro K (1998) Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation. Blood 92:1859-1869
35. Daniel C, Schroder O, Zahn N, Gaschott T, Stein J (2004) p38 MAPK signaling pathway is involved in butyrate-induced vitamin D receptor expression. Biochem Biophys Res Commun 324:1220-1226
36. Witt O, Sand K, Pekrun A (2000) Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways. Blood 95:2391-2396
37. Zhou J, Tang Y, Liu W, Sun H, Hu J, Gong J (2002) Molecular mechanism of enhanced apoptotic response in U937 cells mediated by sodium butyrate. Zhonghua Zhong Liu Za Zhi 24:320-322
38. Ruemmele FM, Dionne S, Qureshi I, Sarma DS, Levy E, Seidman EG (1999) Butyrate mediates Caco-2 cell apoptosis via up-regulation of pro-apoptotic BAK and inducing caspase-3 mediated cleavage of poly-(ADP-ribose) polymerase (PARP). Cell Death Differ 6:729-735
39. Moss SF, Agarwal B, Arber N, et al (1996) Increased intestinal Bak expression results in apoptosis. Biochem Biophys Res Commun 223:199-203
40. Clem RJ, Cheng EH, Karp CL, et al (1998) Modulation of cell death by Bcl-XL through caspase interaction. Proc Natl Acad Sci USA 95:554-559
41. Wang J, Friedman E (2000) Downregulation of p53 by sustained JNK activation during apoptosis. Mol Carcinog 29:179-188
42. Auwerx J (2002) Nuclear receptors. I. PPAR gamma in the gastrointestinal tract: gain or pain? Am J Physiol Gastrointest Liver Physiol 282:G581-585
43. Theocharis S, Margeli A, Vielh P, Kouraklis G (2004) Peroxisome proliferator-activated receptor-gamma ligands as cell-cycle modulators. Cancer Treat Rev 30:545-554
44. Kim EJ, Park KS, Chung SY, et al (2003) Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway. J Pharmacol Exp Ther 307:505-517
45. Li MY, Deng H, Zhao JM, Dai D, Tan XY (2003) PPARgamma pathway activation results in apoptosis and COX-2 inhibition in HepG2 cells. World J Gastroenterol 9:1220-1226
46. Sarraf P, Mueller E, Smith WM, et al (1999) Loss-of-function mutations in PPAR gamma associated with human colon cancer. Mol Cell 3:799-804
47. Bull AW, Steffensen KR, Leers J, Rafter JJ (2003) Activation of PPAR gamma in colon tumor cell lines by oxidized metabolites of linoleic acid, endogenous ligands for PPAR gamma. Carcinogenesis 24:1717-1722
48. Natoni F, Diolordi L, Santoni C, Gilardini Montani MS (2005) Sodium butyrate sensitises human pancreatic cancer cells to both the intrinsic and the extrinsic apoptotic pathways. Biochim Biophys Acta 1745:318-329
49. Kim EH, Kim HS, Kim SU, Noh EJ, Lee JS, Choi KS (2005) Sodium butyrate sensitizes human glioma cells to TRAIL-mediated apoptosis through inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP. Oncogene 24:6877-6889
50. Cheng Y, Chang LW, Tsou TC (2005) Mitogen-activated protein kinases mediate arsenic-induced down-regulation of survivin in human lung adenocarcinoma cells. Arch Toxicol 1-9
51. Qiu L, Wang Q, Di W, et al (2005) Transient activation of EGFR/AKT cell survival pathway and expression of survivin contribute to reduced sensitivity of human melanoma cells to betulinic acid. Int J Oncol 27:823-830
52. Johnson ME, Howerth EW (2004) Survivin: a bifunctional inhibitor of apoptosis protein. Vet Pathol 41:599-607
53. Sanna MG, da Silva Correia J, Ducrey O, et al (2002) IAP suppression of apoptosis involves distinct mechanisms: the TAK1/JNK1 signaling cascade and caspase inhibition. Mol Cell Biol 22:1754-1766
54. Kim Y, Suh N, Sporn M, Reed JC (2002) An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis. J Biol Chem 277:22320-22329
55. Hernandez A, Thomas R, Smith F, et al (2001) Butyrate sensitizes human colon cancer cells to TRAIL-mediated apoptosis. Surgery 130:265-272